Abstract This ISAAC Phase Three synthesis provides summarised information on the main findings of the study, regional tables and figures related to the prevalence and severity of current symptoms of asthma, rhinoconjunctivitis and eczema in the main regions of the world. The large number of surveyed children (≈1,200,000), the large number of centres (233) and countries (98) that participated in ISAAC Phase Three makes this study the most comprehensive survey of these diseases ever undertaken. Globally, the prevalence for current asthma, rhinoconjunctivitis and eczema in the 13---14-year age group was 14.1%, 14.6% and 7.3%, respectively. In the 6---7-year age group the prevalence for current asthma, rhinoconjunctivitis and eczema was 11.7%, 8.5% and 7.9%, respectively. The study shows a wide variability in the prevalence and severity of asthma, rhinoconjunctivitis and eczema which occurs not just between regions and countries but between centres in the same country and centres in the same city. This study definitively establishes that the prevalence of those diseases can be very high in non-affluent centres with low socioeconomic conditions. The large variability also suggests a crucial role of local environment characteristics to determine the differences in prevalence between one place and another. Thus, ISAAC Phase Three has provided a large body of epidemiological information on asthma, rhinoconjunctivitis and eczema in childhood from contrasting environments which is expected to yield new clues about the aetiology of those conditions and reasons for their marked global variability.
Introduction
Asthma, rhinoconjunctivitis and eczema in childhood have become three of the more important public health problems worldwide. Although in the past it was thought that these diseases occurred more frequently in populations from developed countries, it has been evident since the first global report from the International Study of Asthma and Allergies in Childhood (ISAAC) that prevalence of those conditions in some low-resourced countries was similar or even higher than in developed ones and that a wide variability in their prevalence occurred at regional and even at country level. 1---4 Since then, a large body of new national, regional and global information on the prevalence, severity, risk factors, trends and several other aspects related to asthma, rhinoconjunctivitis and eczema in childhood, has been reported by ISAAC. 5 The recently completed third ISAAC Phase included the largest number of centres from the main world regions ever studied in regard to these conditions, with about 1,200,000 schoolchildren surveyed; detailed information on the global prevalence and severity of asthma, rhinitis and eczema has been reported in the ISAAC world map journal articles. 6---8 The well-known methodological consistency of the ISAAC programme, its originality and especially the inclusion of countries with different cultures, socioeconomic development and lifestyles, has led to its results being employed by several governmental and academic institutions at country and regional level. It has constituted the epidemiological basis for many of the well-known global initiatives on asthma, rhinitis and eczema management in childhood, and for guidelines and recommendations from international health organisations.
This article presents new information on disease overlap (asthma, rhinoconjunctivitis, eczema), socioeconomic and geospatial considerations from ISAAC Phase Three (written questionnaires) concerning the prevalence of asthma, rhinoconjunctivitis and eczema in children aged 6---7 and 13---14 years.
Methods
The detailed methodology employed by ISAAC to obtain and analyse data for Phase Three, has already been published in detail elsewhere. 5, 9 Briefly, written questionnaires were self-completed at school by 13---14-year olds and completed at home by parents of 6---7-year olds. Samples of 3000 children for each age group (with a minimum of 1000) within each centre were selected by randomly sampling schools within the study area. Almost all centres studied the 13---14-year age group, but only some centres studied the optional 6---7-year age group. Data checks were undertaken by the ISAAC International Data Centre in Auckland, New Zealand which ensured adherence to the protocol. The English language questionnaire was translated where required, and a back translation to English was provided. In this paper, we focus on the current symptoms (past 12 months) of asthma, rhinoconjunctivitis and eczema; and reported asthma ever.
Associations between prevalence of current symptoms of asthma, rhinoconjunctivitis and eczema, and a range of geo-climatic factors were assessed using maps prepared in the ArcGIS geographic information system (version 9.3.1, ESRI Inc., Redlands, CA, USA). The factors presented are altitude, 10 air pollution as indicated by the predicted concentrations (micro grams per cubic metre) of particulate matter less than 10 m in diameter (PM 10 ), 11 and Gross National Income per capita (GNI). 12 High altitude was Figure 1 Geospatial distribution of prevalence of current symptoms of asthma and country income, 13---14-year age group. Each symbol represents a centre. The four symbols depict different levels of prevalence of symptoms combined with their categorisation as affluent or non-affluent. Red stars indicate high prevalence of current symptoms of asthma (≥10%) and affluent (GNI > $9265); yellow diamonds indicate high prevalence of current symptoms of asthma and non-affluent; green circles indicate low prevalence of current symptoms of asthma and affluent; and blue squares indicate low prevalence of current symptoms of asthma and nonaffluent. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of the article.) Figure 2 Geospatial distribution of prevalence of current symptoms of asthma and altitude, 13---14-year age group. Each symbol represents a centre. The four symbols depict different levels of prevalence of symptoms combined with their categorisation as low or high altitude. Red stars indicate high prevalence of current symptoms of asthma (≥10%) and high altitude (≥300 m); yellow diamonds indicate high prevalence of current symptoms of asthma and low altitude; green circles indicate low prevalence of current symptoms of asthma and high altitude; and blue squares indicate low prevalence of current symptoms of asthma and low altitude.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of the article.) defined as ≥300 m. High PM 10 was defined as ≥50 g/m 3 .
Data for altitude and air pollution were available at centre level whereas the GNI data were only available at country level. Non-affluent countries were those classified by the World Bank as low, lower middle, or upper middle income, and affluent countries are those classified as high income. The maps illustrate the distribution of low and high values of prevalence and GNI, altitude and PM 10 . For current symptoms of asthma (current wheeze) and current symptoms of eczema, high prevalence centres were defined Figure 3 Geospatial distribution of prevalence of current symptoms of asthma and particulate matter (PM 10 ), 13---14-year age group. Each symbol represents a centre. The four symbols depict different levels of prevalence of symptoms combined with their categorisation as low or high (PM 10 ). Red stars indicate high prevalence of current symptoms of asthma (≥10%) and high PM 10 (≥50 g/m 3 ); yellow diamonds indicate high prevalence of current symptoms of asthma and low PM 10 ; green circles indicate low prevalence of current symptoms of asthma and high PM 10 ; and blue squares indicate low prevalence of current symptoms of asthma and low PM 10 . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of the article.) as those with prevalence of 10% or greater. For current symptoms of rhinoconjunctivitis, high prevalence centres were defined as those with prevalence of 15% or greater for the 13---14-year age group and 7.5% or greater for the 6---7-year age group. These definitions are based on the levels used in the maps presented in the ISAAC prevalence papers. 1---4,6---8 Spearman correlation (rho) was used to study the association of altitude, latitude and longitude with the prevalence of current symptoms of asthma, rhinoconjunctivitis and eczema.
Spearman's correlation (rho) was employed to determine associations between current symptoms of asthma, rhinoconjunctivitis and eczema, with centre level altitude, latitude, longitude and PM 10 , and with country level GNI, in 6---7-year and 13---14-year age groups.
Results

Participants
ISAAC Phase Three surveyed about 1,200,000 children from 233 centres in 98 countries, involving almost 800,000 children aged 13---14 years and almost 400,000 aged 6---7 years. For asthma the data sets comprised 1,187,496 schoolchildren from 233 centres in 98 countries, of whom 128 centres (689,413 participants) in 64 countries (34 countries new to ISAAC) had not undertaken ISAAC Phase One; 798,685 were aged 13---14 years and 388,811 were aged 6---7 years. The majority of the new ISAAC centres were from countries in Latin America, Eastern Europe and Africa, although there were also some from other regions. 7 In the case of rhinoconjunctivitis, the 13---14-year age group involved 670,242 children and 388,811 children aged 6---7 years. Regarding eczema, for the 13---14-year age group there were 663,256 children and 385,853 for the 6---7-year age group. 8 Of the 54 languages used in Phase Three, English was the most common (21% of centres) followed by Spanish (20%), Portuguese (11%), Arabic (7%), Italian (6%), French (5%) and Chinese (4%). The number of participating centres per region ranged from seven in North America to 56 in Latin America.
Symptoms by region and gender
The regional prevalences of current symptoms for the three conditions are shown in Tables 1 and 2 by gender.
There was large variability of prevalence between regions for symptoms of each of the three conditions and both age groups. For the younger age group the lowest prevalence values for asthma symptoms were found in the Indian Subcontinent, with intermediate values in Africa, Asia-Pacific, Eastern Mediterranean, Northern and Table 2 Prevalence of current symptoms of asthma, rhinoconjunctivitis and eczema by region and gender, 13---14-year age group.
Region
Gender N Asthma Rhinoconjunctivitis Eczema The summaries by gender for symptoms of each of the three diseases and both age groups showed that in the younger age group there were more boys than girls with asthma and rhinoconjunctivitis symptoms, and this held true for all regions for asthma, and most for rhinoconjunctivitis symptoms, but eczema symptoms overall were more common in girls although this varied across the regions. In the older age group there were more girls than boys with symptoms of all three conditions, and this held true for most regions.
Concurrent prevalence of symptoms of current asthma, rhinoconjunctivitis and eczema
A low proportion of children simultaneously reported current symptoms of asthma, rhinoconjunctivitis and eczema. Amongst the world regions there was a large variability in the prevalence of the three diseases; for those with current symptoms of asthma the prevalence for the concurrence of the three conditions varied from 6.3% in Northern and Eastern Europe to 13.6% in Africa in the 13---14 years old group and from 5.1% in the Indian Subcontinent to 11.9% in Africa in those aged 6---7 years. The relative proportions for the regional concurrent prevalence of the three diseases are presented in Tables 3---8. The global prevalence of current symptoms of the three diseases reported simultaneously by children is shown in Fig. 4 .
Prevalence in centres related to socioeconomic status of countries
In both, the 6---7 and 13---14-year age groups, GNI was positively correlated (Spearman's rho) with current symptoms of asthma, rhinoconjunctivitis and eczema ( Table 9 ). The geospatial distribution of current symptoms of asthma and Document downloaded from http://www.elsevier.es, day 27/11/2018. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. GNI is shown in Fig. 1 . There are four patterns of centres shown: a high prevalence in affluent centres; a high prevalence in non-affluent centres; a low prevalence in affluent centres; and a low prevalence in non-affluent centres.
Geo-climatic factors and their relationship with current prevalence of asthma, rhinoconjunctivitis and eczema
Globally, it was found that lower latitudes and Eastern longitudes were slightly but significantly associated with higher prevalence of current symptoms of asthma, and rhinoconjunctivitis and eczema in both age groups (Table 9 ). However, this was not a consistent finding. For instance, in large regions including both hemispheres as Latin America, no significant association was found between latitude/longitude and prevalence of current symptoms. The mean prevalence of the three diseases was similar in centres located in tropical versus non-tropical areas. The distribution of prevalence of current symptoms by altitude in the group aged 13---14 years (Fig. 5) showed a weak but significant inverse correlation just for current asthma but not for rhinoconjunctivitis or eczema; in the 6---7-year age group there was a weak but significant inverse Figure 4 Overall proportions of children with current symptoms of asthma, rhinoconjunctivitis, or eczema, or combinations of symptoms, 6---7-year age group (A) and 13---14-year age group (B) for ISAAC Phase Three. (Table 9 ).
Particulate matter less than or equal to 10 m (PM 10 ) and the relationship with current prevalence of asthma, rhinoconjunctivitis and eczema
Overall, ISAAC Phase Three found that PM 10 showed a trend to be inversely related with current symptoms of asthma, rhinoconjunctivitis and eczema at level centre; however, the relationship was inconsistent or null at within-country level.
Discussion
This is the largest study of asthma, rhinoconjunctivitis and eczema ever conducted, and the first time that the relationship between the three diseases, and various geospatial and geo-climatic phenomena has been examined. ISAAC Phase Three was performed in all WHO regions thus the main continents and ethnic areas of the world were represented in the study.
The large variability of prevalence between regions, continents, countries, centres in the same country, and even between centres in the same city (as in Mexico City) is probably the main and most consistent finding of ISAAC. 6---8 The marked difference of prevalence between centres in the same city, as occurred in Mexico City, has also been found amongst New York neighbourhoods, with a 3---19% difference in asthma prevalence across the city associated with variations in allergen exposures. 13 This highlights the heightened impact of still undefined local environmental or ecologic factors present at each centre, which may determine varying epidemiological and clinical expressions of diseases in populations at similar settings. 14---16 The latter, i.e. the influence of local variation in exposures on prevalence, seems to be supported by the large variability found amongst centres in the prevalence of allergen sensitisation 17 and airway hyperresponsiveness. 18 Although the whole study found a subtle relationship between GNI and overall symptom prevalence, in large regions such as Latin America (56 centres in 17 countries), which accounted for about 25% of all the children surveyed by ISAAC Phase Three in the world, 19 there was not a significant correlation between GNI and prevalence. Using the GNI or other country-average index to study the effect of socioeconomic status on the prevalence of current symptoms, especially when including centres from affluent and non-affluent countries, may be misleading, since the income distribution in developing countries is highly unequal. Therefore, assigning the GNI of a developing country to all centres in that country would be inadequate because the risk of losing the large differences in income distribution between centres in developing countries, and regions. 20 Until socioeconomic data at an individual level are available for all participating centres, the effect of socioeconomic development on the prevalence and severity of asthma, rhinoconjunctivitis and eczema will be bedevilled by this methodological issue. The results of studies looking at the relationship between socioeconomic status and prevalence of symptoms vary from an inverse association, 21---24 to no association 25 to a positive association 26 ; apart from methodological considerations which may reflect the lack of proper and standardised instruments to assess such associations at centre or individual level.
Higher or lower prevalence of current symptoms of asthma, rhinoconjunctivitis and eczema occurred regardless of whether centres were located in developing or developed countries or regions, 1,2,5---8 and this was consistent with the findings of ISAAC Phase One. 2 For instance, in Africa the 13---14-year age group had the same mean prevalence of current wheezing as Western Europe (14%); similar prevalence of rhinoconjunctivitis and eczema also occurred between developing and developed countries, as shown in Tables 1 and 2 . In general, most centres with a high or low prevalence in Phase Three tended to remain close to the level of prevalence they had in Phase One; although there were some centres showing important increases or decreases between the two phases. In areas sharing the same language but different socioeconomic development, the prevalence of current asthma symptoms was higher in developing than developed countries (i.e., Iberian Peninsula vs. Latin America). 19 The inclusion of many more centres from developing countries in Phase Three than in Phase One is an important achievement of ISAAC as the proportion of the world population that lives in developing areas is about 80%. This is important because several theories on asthma causation are related to the protective effect of factors usually associated with low socioeconomic status. Considering that conditions of poverty have been persistently affecting populations in developing areas for a long time, without dramatic changes in the last 20 years, a lower prevalence of asthma, rhinoconjunctivitis, and eczema would have been expected in children and adolescents from those lowresourced countries. The participation of many more centres from developing countries certainly provides a more realistic representation of the world prevalence of asthma, rhinoconjunctivitis and eczema in childhood. At present, and thanks to the information gathered by ISAAC, the old statement that asthma was just a disease of industrialised and developed countries can be considered simply as an exclusion bias.
As in Phase One, most symptomatic children had symptoms of only one disorder in the previous year, which indicates that many different risk factors may be required for the clinical expression of these related disorders or may involve different time of occurrence, latency periods and time trends.
Although the proportion of subjects having the three diseases simultaneously was relatively low, those children probably represent a highly demanding group for specialised health care. Furthermore, it is likely that as seen in daily practice, coexistence of these diseases may be associated with greater functional impairment in terms of activity limitation and lower quality of life as compared to children who have one condition alone. Co-morbidities are important for clinicians treating asthma as they may be markers of patients at risk of poor outcomes, they may point to specific effective treatment options and they are important to researchers as possible confounding factors in clinical trials.
The effect of geo-climatic factors on the current symptom prevalence should be interpreted cautiously because of the dynamic nature of climatic factors that sometimes act independently of latitude and longitude, as is apparently occurring in this last decade. Consequently, geo-climatic factors should be considered as part of a much more complex model interacting with several other ecological conditions which also could be altered by seasonal or yearly changes. As other authors previously found, 27,28 ISAAC Phase Three found correlations between some geo-climatic factors and the prevalence of asthma, rhinoconjunctivitis and eczema; however, the interpretation and time-dependency of such effects remains difficult to understand.
The complex relationships between air pollution and symptoms of asthma, rhinoconjunctivitis and eczema probably cannot be elucidated from data as those obtained by ISAAC. Further information on the type, magnitude and temporality of exposures, which also consider variations caused by geo-climatic (i.e. seasonal) factors, should help to a better understanding of the true effects of air pollution on the prevalence of asthma, rhinoconjunctivitis and eczema in children.
Limitations
In some way, ISAAC shares the potential limitations of any large multicentre international cross-sectional study (differences in language, socioeconomic development, lifestyle, cultural standard, environmental aspects, educational level, medical practice and health concepts, amongst others). We acknowledge the limitations of international prevalence comparisons of this kind and also of interpretations on its findings. Another concern is that centre GNI was assumed to be the same as country GNI. Unfortunately, for most of the centres in developing countries or regions there is no official information available regarding socioeconomic status. At present, it is clear that in those countries or areas with huge inequities of income distribution 19 the wholesale application of a country level measure to all centres conceals more than it reveals.Nevertheless, the worldwide scope of ISAAC Phase Three including centres across the main world regions, the use of standardised and validated methodology, a meticulous translation of questionnaires to different languages, 29 strict data quality control and management, and a thorough repetition of the study after several years, has provided for the first time a unique and fundamental epidemiological analysis of the world distribution and trend of the prevalence and severity of asthma, rhinoconjunctivitis and eczema in children. 30 At the same time ISAAC has provided a stimulus for the development of new hypotheses and a challenge to identify modifiable protective and risk factors for asthma, and the other diseases studied. The worldwide time trends in the prevalence of current symptoms are not described in the present paper because they have been extensively detailed elsewhere. 31---33 As found in ISAAC Phase One, there was a low degree of overlap between the three conditions 2 suggesting that asthma, rhinoconjunctivitis and eczema may have different aetiologies, time of occurrence and clinical course, probably related with particular enviromental exposures at each locality or area.The wide variability of the prevalence of the studied diseases, found by ISAAC in all its phases, strongly points to local ecological factors or exposures which are probably typical for each locality, as the main determinants for the observed variability of symptoms, allergic sensitisation and airways hyperresponsiveness reported by recent ISAAC studies. The latter is in accordance with current research on how and when exposures to environmental agents can induce epigenetic changes that will result in varying biological, clinical and epidemiological expressions of asthma and allergies. 14---16 Another most successful task of ISAAC Phase Three was the consolidation of a world research force based on a huge scientific, trained and efficient network, throughout the continents and main regions of the planet and despite the marked differences in cultural and environmental aspects amongst participating countries and centres. Ellwood et al. have found that the majority of centres in this repeat multi-centre international research project undertaken by researchers with diverse cultural backgrounds were able to replicate the methodology between phases (data not shown).
The ISAAC programme has demonstrated that it is feasible to monitor the prevalence and severity of asthma, rhinoconjunctivitis, and eczema in children, globally. It is possible that prevalence of current symptoms of asthma rhinoconjunctivitis and eczema, as well as those factors that could induce changes on it, may behave accordingly to the important environmental and climatic changes presently occurring in the world. ISAAC Phase Three has extended, updated and disseminated valuable epidemiological information on asthma, rhinoconjunctivitis and eczema in childhood, proposing new hypotheses, contrasting old ones and modernising the basis for further aetiological research into the genetic, lifestyle, environmental, clinical and medical-care factors for those diseases.
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